Desidustat

DRUG3 trials

Sponsors

Zydus Lifesciences Limited

Conditions

Anemia of Chronic Kidney DiseaseCOVID-19Chemotherapy EffectChronic Kidney Diseases

Phase 1

Desidustat in the Treatment of Chemotherapy Induced Anemia

CompletedNCT04667533

Zydus Lifesciences LimitedAnemia of Chronic Kidney Disease, Chemotherapy Effect

Start: 2020-11-11End: 2022-05-10Updated: 2022-05-18

Phase 2

Desidustat in the Management of COVID-19 Patients

CompletedNCT04463602

Zydus Lifesciences LimitedCOVID-19

Start: 2020-07-25End: 2021-03-31Updated: 2021-04-23

Phase 4

A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)

RecruitingNCT05515367

Zydus Lifesciences LimitedAnemia of Chronic Kidney Disease, Chronic Kidney Diseases

Start: 2023-04-20End: 2025-11-30Target: 1004Updated: 2025-01-22